Microangiopathic hemolytic anemia (MAHA) is a microangiopathic subgroup of hemolytic anemia (loss of red blood cells through destruction) caused by factors in the small blood vessels. It is …

2022年12月9日 · Thrombotic microangiopathy (TMA) is a pathologic lesion characterized clinically by the presence of microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and …

2004年12月13日 · Microangiopathic hemolysis (MAHA) related to malignant hypertension may cause renal insufficiency by obstruction of interlobular arteries. We hypothesized that the …

Microangiopathic hemolysis (MAHA) related to malignant hypertension may cause renal insufficiency by obstruction of interlobular arteries. We hypothesized that the presence of …

RBC fragments (schistocytes) are used to diagnose MAHA upon blood smears. It is hemolysis brought on by RBC destruction from mechanical forces. MAHA is referred to as …

2023年7月26日 · Carfilzomib is an effective therapy for multiple myeloma. However, carfilzomib-induced thrombotic microangiopathy (TMA) has emerged as a potential severe complication, …

Thrombotic microangiopathy (TMA) is a debilitating complication of kidney transplantation that is associated with poor patient and graft outcomes. The incidence of post-transplant TMA has …

These patients will show characteristic clinical symptoms with fever, thrombocytopenia, and microangiopathic hemolytic anemia accompanied by multi- organ failure, often manifest as …

The occurrence of acute kidney injury (AKI) in adults associated with microangiopathic hemolytic anemia (MAHA) and thrombocytopenia presents diagnostic and therapeutic challenges, as …

Usually, these disease processes are characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and microthrombi leading to tissue or organ injury. We present a …